Noeker M, Haverkamp F
Center for Pediatrics of the University of Bonn, Germany.
J Pediatr Endocrinol Metab. 2000 Nov-Dec;13(9):1585-94. doi: 10.1515/jpem.2000.13.9.1585.
A major justification of extended indications for GH therapy in conditions with short stature is based on the objective of preventing or alleviating suspected psychosocial maladjustment. Despite more sophisticated research, results are still controversial concerning the actual seriousness of adjustment difficulties in various conditions with short stature, thus making it difficult to determine a patient's need for treatment. This paper discusses different concepts and assessment strategies of "adjustment" as a major source of the apparent heterogeneity among study findings, conclusions and treatment recommendations. A concise framework is developed that identifies and differentiates three hierarchical levels of research on adjustment in conditions with growth retardation: (1) stress exposure due to short stature, (2) quality of coping responses, and (3) occurrence of psychopathology. Choosing a particular research level and its corresponding measures may imply whether a high, medium or very low impact of short stature on adjustment is found, and the need for treatment that is inferred. The integration of these different research approaches within an integrative model may help to resolve apparent inconsistencies among empirical studies and reveal sources of confoundation due to other, short stature independent risk factors associated with the particular underlying growth disorder. The key terms of the suggested model are transformed into a clinical guideline for psychological assessment in patients with growth retardation and into three key criteria for the decision making process on extended indications for GH treatment with respect to the improvement of psychosocial adjustment.
在身材矮小的情况下,生长激素(GH)治疗扩大适应症的一个主要理由是基于预防或减轻疑似心理社会适应不良的目标。尽管有更复杂的研究,但关于各种身材矮小情况下适应困难的实际严重程度,结果仍存在争议,因此难以确定患者的治疗需求。本文讨论了“适应”的不同概念和评估策略,这是研究结果、结论和治疗建议中明显异质性的主要来源。本文构建了一个简明框架,识别并区分了生长发育迟缓情况下适应研究的三个层次水平:(1)身材矮小导致的压力暴露,(2)应对反应的质量,以及(3)精神病理学的发生。选择特定的研究水平及其相应的测量方法可能意味着身材矮小对适应的影响是高、中还是非常低,以及由此推断出的治疗需求。将这些不同的研究方法整合到一个综合模型中,可能有助于解决实证研究之间明显的不一致,并揭示由于与特定潜在生长障碍相关的其他独立于身材矮小的风险因素导致的混淆来源。所建议模型的关键术语被转化为生长发育迟缓患者心理评估的临床指南,以及关于扩大生长激素治疗适应症以改善心理社会适应的决策过程的三个关键标准。